Literature DB >> 21171592

Novel pyrrolopyrimidine-based α-helix mimetics: cell-permeable inhibitors of protein−protein interactions.

Ji Hoon Lee1, Qi Zhang, Sunhwan Jo, Sergio C Chai, Misook Oh, Wonpil Im, Hua Lu, Hyun-Suk Lim.   

Abstract

There is considerable interest in developing non-peptidic, small-molecule α-helix mimetics to disrupt α-helix-mediated protein−protein interactions. Herein, we report the design of a novel pyrrolopyrimidine-based scaffold for such α-helix mimetics with increased conformational rigidity. We also developed a facile solid-phase synthetic route that is amenable to divergent synthesis of a large library. Using a fluorescence polarization-based assay, we identified cell-permeable, dual MDMX/MDM2 inhibitors, demonstrating that the designed molecules can act as α-helix mimetics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21171592      PMCID: PMC3079198          DOI: 10.1021/ja108230s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  37 in total

1.  High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.

Authors:  Anna Czarna; Grzegorz M Popowicz; Aleksandra Pecak; Siglinde Wolf; Grzegorz Dubin; Tad A Holak
Journal:  Cell Cycle       Date:  2009-04-16       Impact factor: 4.534

2.  Structure-based design of high affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX.

Authors:  Jason Phan; Zhenyu Li; Agnieszka Kasprzak; Baozong Li; Said Sebti; Wayne Guida; Ernst Schönbrunn; Jiandong Chen
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

Review 3.  Prodrug approaches for enhancing the bioavailability of drugs with low solubility.

Authors:  Christa E Müller
Journal:  Chem Biodivers       Date:  2009-11       Impact factor: 2.408

4.  Assessment of helical interfaces in protein-protein interactions.

Authors:  Andrea L Jochim; Paramjit S Arora
Journal:  Mol Biosyst       Date:  2009-04-08

5.  Bridged beta(3)-peptide inhibitors of p53-hDM2 complexation: correlation between affinity and cell permeability.

Authors:  Arjel D Bautista; Jacob S Appelbaum; Cody J Craig; Julien Michel; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2010-03-10       Impact factor: 15.419

6.  Oligooxopiperazines as nonpeptidic alpha-helix mimetics.

Authors:  Petra Tosovská; Paramjit S Arora
Journal:  Org Lett       Date:  2010-04-02       Impact factor: 6.005

7.  N-acylpolyamine inhibitors of HDM2 and HDMX binding to p53.

Authors:  Ryo Hayashi; Deyun Wang; Toshiaki Hara; Jaclyn A Iera; Stewart R Durell; Daniel H Appella
Journal:  Bioorg Med Chem       Date:  2009-10-21       Impact factor: 3.641

8.  Novel amphiphilic alpha-helix mimetics based on a bis-benzamide scaffold.

Authors:  Srinivasa Marimganti; Murthy N Cheemala; Jung-Mo Ahn
Journal:  Org Lett       Date:  2009-10-01       Impact factor: 6.005

9.  Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions.

Authors:  Alex Shaginian; Landon R Whitby; Sukwon Hong; Inkyu Hwang; Bilal Farooqi; Mark Searcey; Jiandong Chen; Peter K Vogt; Dale L Boger
Journal:  J Am Chem Soc       Date:  2009-04-22       Impact factor: 15.419

10.  In Silico Improvement of beta3-peptide inhibitors of p53 x hDM2 and p53 x hDMX.

Authors:  Julien Michel; Elizabeth A Harker; Julian Tirado-Rives; William L Jorgensen; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2009-05-13       Impact factor: 15.419

View more
  43 in total

1.  Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.

Authors:  Holly S Haase; Kimberly J Peterson-Kaufman; Sheeny K Lan Levengood; James W Checco; William L Murphy; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2012-05-01       Impact factor: 15.419

2.  Design, synthesis and protein-targeting properties of thioether-linked hydrogen bond surrogate helices.

Authors:  Andrew B Mahon; Paramjit S Arora
Journal:  Chem Commun (Camb)       Date:  2011-09-28       Impact factor: 6.222

Review 3.  Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.

Authors:  Shaoyong Lu; Hyunbum Jang; Shuo Gu; Jian Zhang; Ruth Nussinov
Journal:  Chem Soc Rev       Date:  2016-07-11       Impact factor: 54.564

4.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

5.  Evaluating minimalist mimics by exploring key orientations on secondary structures (EKOS).

Authors:  Dongyue Xin; Eunhwa Ko; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  Org Biomol Chem       Date:  2013-10-14       Impact factor: 3.876

6.  A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings.

Authors:  Jianzhong Chen; Jinan Wang; Weiliang Zhu; Guohui Li
Journal:  J Comput Aided Mol Des       Date:  2013-11-22       Impact factor: 3.686

7.  Potential pharmacological chaperones targeting cancer-associated MCL-1 and Parkinson disease-associated α-synuclein.

Authors:  Misook Oh; Ji Hoon Lee; Wei Wang; Hui Sun Lee; Woo Sirl Lee; Christopher Burlak; Wonpil Im; Quyen Q Hoang; Hyun-Suk Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

Review 8.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules.

Authors:  Valeria Azzarito; Kérya Long; Natasha S Murphy; Andrew J Wilson
Journal:  Nat Chem       Date:  2013-03       Impact factor: 24.427

Review 9.  Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.

Authors:  Xu Ran; Jason E Gestwicki
Journal:  Curr Opin Chem Biol       Date:  2018-06-13       Impact factor: 8.822

10.  Identification of small molecules affecting p53-MDM2/MDMX interaction by fluorescence polarization.

Authors:  Qi Zhang; Hua Lu
Journal:  Methods Mol Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.